Tagged With heather bresch

People around the world depend on their EpiPen to work in the case of life-threatening allergic reactions. But two people recently found out the hard way that their EpiPens were faulty. As a result, the makers of EpiPen are recalling over 81,000 EpiPens in Australia, New Zealand, Norway, Denmark, Finland, Ireland and Japan.

Last week, Heather Bresch, the CEO of Mylan Pharmaceuticals, testified in front of the US Congress about why the company has raised the price of EpiPen from roughly $US57 ($75) in 2007 to $US600 ($785) in the US today. (EpiPens are subsidised in Australia and typically under $100). Under intense questioning, she claimed that the company only makes about $US100 ($131) per two-pack of EpiPens. Today the company was forced to "clarify" that the price was actually higher. They make $US160 ($209).